Your browser doesn't support javascript.
loading
Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: An individual participant data meta-analysis of 73 primary studies.
Wu, Yin; Levis, Brooke; Sun, Ying; Krishnan, Ankur; He, Chen; Riehm, Kira E; Rice, Danielle B; Azar, Marleine; Yan, Xin Wei; Neupane, Dipika; Bhandari, Parash Mani; Imran, Mahrukh; Chiovitti, Matthew J; Saadat, Nazanin; Boruff, Jill T; Cuijpers, Pim; Gilbody, Simon; McMillan, Dean; Ioannidis, John P A; Kloda, Lorie A; Patten, Scott B; Shrier, Ian; Ziegelstein, Roy C; Henry, Melissa; Ismail, Zahinoor; Loiselle, Carmen G; Mitchell, Nicholas D; Tonelli, Marcello; Al-Adawi, Samir; Beraldi, Anna; Braeken, Anna P B M; Büel-Drabe, Natalie; Bunevicius, Adomas; Carter, Gregory; Chen, Chih-Ken; Cheung, Gary; Clover, Kerrie; Conroy, Ronán M; Cukor, Daniel; da Rocha E Silva, Carlos E; Dabscheck, Eli; Daray, Federico M; Douven, Elles; Downing, Marina G; Feinstein, Anthony; Ferentinos, Panagiotis P; Fischer, Felix H; Flint, Alastair J; Fujimori, Maiko; Gallagher, Pamela.
Afiliação
  • Wu Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada; Department of Psychiatry, McGill University, Montréal, QC, Canada.
  • Levis B; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
  • Sun Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • Krishnan A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • He C; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • Riehm KE; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Rice DB; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Psychology, McGill University, Montréal, QC, Canada.
  • Azar M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
  • Yan XW; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • Neupane D; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
  • Bhandari PM; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
  • Imran M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • Chiovitti MJ; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • Saadat N; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • Boruff JT; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, QC, Canada.
  • Cuijpers P; EMGO Institute, Vrije Universiteit Amsterdam, the Netherlands.
  • Gilbody S; Hull York Medical School and the Department of Health Sciences, University of York, Heslington, York, UK.
  • McMillan D; Hull York Medical School and the Department of Health Sciences, University of York, Heslington, York, UK.
  • Ioannidis JPA; Department of Clinical, Neuro and Developmental Psychology, Department of Medicine, Department of Health Research and Policy, Department of Biomedical Data Science, Department of Statistics, Stanford University, Stanford, CA, USA.
  • Kloda LA; Library, Concordia University, Montréal, QC, Canada.
  • Patten SB; Departments of Community Health Sciences and Psychiatry, University of Calgary, Calgary, AB, Canada; Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, Canada; Cuthbertson & Fischer Chair in Pediatric Mental Health, University of Calgary, Calgary, Canada.
  • Shrier I; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada; Department of Family Medicine, McGill University, Montréal, QC, Canada.
  • Ziegelstein RC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Henry M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
  • Ismail Z; Hotchkiss Brain Institute & O'Brien Institute for Public Health, Calgary, AB, Canada; Department of Psychiatry, Clinical Neuroscience and Community Health Sciences, University of Calgary, Calgary, AB, Canada; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Loiselle CG; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Ingram School of Nursing, McGill University, Montréal, QC, Canada; Centre for Nursing Research, Jewish General Hospital, Montréal, QC, Canada; Department of Oncology, Faculty of Medicine, McGill University, Mon
  • Mitchell ND; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada; Alberta Health Services, Edmonton, AB, Canada.
  • Tonelli M; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Al-Adawi S; Department of Behavioural Medicine, College of Medicine & Health Sciences, Sultan Qaboos University, Oman, Oman.
  • Beraldi A; Psychotherapie und Psychsomatik, kbo Lech-Mangfall-Klinik für Psychatrie, Garmisch-Partenkirchen, Bayern, Germany.
  • Braeken APBM; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands; Faculty of Psychology, Open University of the Netherlands, Heerlen, the Netherlands; Department of Health Services Research, CAPHRI Sch
  • Büel-Drabe N; Department of Psychiatry and Psychotherapy, University Hospital Zürich, Zürich, Switzerland.
  • Bunevicius A; Harvard University, Boston, MA, USA; Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Carter G; University of Newcastle, Australia; Calvary Mater Newcastle, Australia.
  • Chen CK; Community Medicine Research Center, Keelung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Keelung, Taiwan; Department of Psychiatry, Keelung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Keelung, Taiwan.
  • Cheung G; University of Auckland, Auckland, New Zealand.
  • Clover K; Centre for Brain and Mental Health Research, University of Newcastle, NSW, Australia.
  • Conroy RM; Royal College of Surgeons in Ireland Division of Population Health Sciences, Dublin, Ireland.
  • Cukor D; Rogosin Institute, NY, New York, USA.
  • da Rocha E Silva CE; Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Dabscheck E; The Alfred Hospital, Prahran, VIC, Australia; Monash University, Melbourne, Australia.
  • Daray FM; National Scientific and Technical Research Council, Buenos Aires, Argentina; Institute of Pharmacology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
  • Douven E; Alzheimer Center Limburg and School for Mental Health and Neuroscience (MHeNs), Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
  • Downing MG; School of Psychological Sciences, Monash University, Melbourne, VIC, Australia; Monash Epworth Rehabilitation Research Centre, Epworth HealthCare, Melbourne, VIC, Australia.
  • Feinstein A; University of Toronto, Toronto, ON, Canada; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Ferentinos PP; 2nd Department of Psychiatry, Attikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece; Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
  • Fischer FH; Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Flint AJ; University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Fujimori M; Section of Psychological Science, Division of Health Care Research, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
  • Gallagher P; School of Psychology, Dublin City University, Dublin, Ireland.
J Psychosom Res ; 129: 109892, 2020 02.
Article em En | MEDLINE | ID: mdl-31911325
ABSTRACT

OBJECTIVE:

Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D).

METHODS:

Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and Mini International Neuropsychiatric Interview (MINI), controlling for HADS-D scores and participant characteristics with and without an interaction term between interview and HADS-D scores.

RESULTS:

There were 15,856 participants (1942 [12%] with major depression) from 73 studies, including 15,335 (97%) non-psychiatric medical patients, 164 (1%) partners of medical patients, and 357 (2%) healthy adults. The MINI (27 studies, 7345 participants, 1066 major depression cases) classified participants as having major depression more often than the CIDI (10 studies, 3023 participants, 269 cases) (adjusted odds ratio [aOR] = 1.70 (0.84, 3.43)) and the semi-structured SCID (36 studies, 5488 participants, 607 cases) (aOR = 1.52 (1.01, 2.30)). The odds ratio for major depression classification with the CIDI was less likely to increase as HADS-D scores increased than for the SCID (interaction aOR = 0.92 (0.88, 0.96)).

CONCLUSION:

Compared to the SCID, the MINI may diagnose more participants as having major depression, and the CIDI may be less responsive to symptom severity.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escalas de Graduação Psiquiátrica / Transtorno Depressivo Maior Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escalas de Graduação Psiquiátrica / Transtorno Depressivo Maior Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article